Found: 2
Select item for more details and to access through your institution.
A Novel Allogeneic Rituximab-Conjugated Gamma Delta T Cell Therapy for the Treatment of Relapsed/Refractory B-Cell Lymphoma.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4844, doi. 10.3390/cancers15194844
- By:
- Publication type:
- Article
A Novel off-the-Shelf Trastuzumab-Armed NK Cell Therapy (ACE1702) Using Antibody-Cell-Conjugation Technology.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2724, doi. 10.3390/cancers13112724
- By:
- Publication type:
- Article